Anjarium Biosciences

📍 Schlieren, Switzerland🗓 Founded 2017👥 35 employees💰 Last funded Aug 2021
Biotechnology🌐 anjarium.com
Website LinkedIn
Anjarium Biosciences AG is a genetic medicines company focused on creating and delivering a new generation of targeted gene therapies to patients. Anjarium’s versatile platform builds on novel therapeutic payloads and delivery technologies, with the aim to unlock the full potential of gene therapy.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2017
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Belgium
1
Frequently asked questions
Who invested in Anjarium Biosciences?
Anjarium Biosciences has 1 investors on record on gritt.io, 1 mid-stage.
When did Anjarium Biosciences last raise funding?
The most recent investment in Anjarium Biosciences recorded on gritt.io was in August 2021.
When was Anjarium Biosciences founded?
Anjarium Biosciences was founded in 2017.
What industry is Anjarium Biosciences in?
Anjarium Biosciences operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Anjarium Biosciences based?
Anjarium Biosciences is headquartered in Schlieren, Switzerland.